Research Groups
Models of Advanced Prostate Cancer |
Clinical Research |
CRUK BI, Garscube |
|
Translational Cancer Research |
Translational Cancer Research |
WWCRC, Garscube |
|
Epithelial Polarity |
Invasion and Metastasis |
CRUK BI, Garscube |
|
Translational Radiation Biology |
Clinical Research |
Beatson CC, Gartnavel Hospital |
|
Translational Cancer Research |
Translational Cancer Research |
WWCRC, Garscube |
|
Leukaemia Stem Cell Self-Renewal Group |
Leukaemia Research Centre |
PoGLRC, Gartnavel Hospital |
|
Stem cells in tissue homeostasis and transformation |
Epigenetics |
WWCRC, Garscube |
|
Translational Cancer Pathology |
Experimental Therapeutics |
WWCRC, Garscube |
|
ICS Clinical Director, Head of Unit, Translational Cancer Therapeutics |
Experimental Therapeutics |
CRUK BI, Garscube |
|
Leukaemia and Autophagy Therapeutics |
Leukaemia Research Centre |
WWCRC, Garscube |
|
Mechanisms of CNS disease in childhood acute lymphoblastic leukaemia (ALL) |
Experimental Therapeutics |
WWCRC, Garscube |
|
Ubiquitin Signalling |
Beatson Institute |
CRUK BI, Garscube |
|
Cell Migration and Chemotaxis |
Beatson Institute |
CRUK BI, Garscube |
|
Targeting Hematologic Malignancy |
Leukaemia Research Centre |
PoGLRC, Gartnavel Hospital |
|
Spatial Segregation of Signalling |
Beatson Institute |
CRUK BI, Garscube |
|
Urological Oncology |
Clinical Research |
Beatson CC, Gartnavel Hospital |
|
Normal and Leukaemic Stem Cells |
Leukaemia Research Centre |
PoGLRC, Gartnavel Hospital |
|
Biology of Paediatric and Adult Acute Leukaemias |
Leukaemia Research Centre |
PoGLRC, Gartnavel Hospital |
|
Telomerase Therapeutics |
Experimental Therapeutics |
WWCRC, Garscube |
|
Prostate Cancer Biology |
Clinical Research |
CRUK BI, Garscube |
|
Migration, Invasion and Metastasis |
Beatson Institute |
CRUK BI, Garscube |
|
Clinical Oncology |
Experimental Therapeutics |
CRUK BI, Garscube |
|
Targeting Cancer Specific Amino Acid Metabolism |
Experimental Therapeutics |
CRUK BI, Garscube |
|
Mechanisms responsible for the initiation and progression of CLL |
Leukaemia Research Centre |
PoGLRC, Gartnavel Hospital |
|
Oncogene-Induced Vulnerabilities |
Beatson Associate |
CRUK BI, Garscube |
|
Integrin Cell Biology |
Beatson Institute |
CRUK BI, Garscube |
|
Systems Pathology of Cancer |
Molecular Pathology |
WWCRC, Garscube |
|
Clinical Trials Unit |
Clinical Research |
Beatson CC, Gartnavel Hospital |
|
Medical Oncology |
Experimental Therapeutics |
CRUK BI, Garscube |
|
Tumour Cell Death |
Beatson Institute |
CRUK BI, Garscube |
|
Colorectal Cancer and Wnt Signalling |
Beatson Institute |
CRUK BI, Garscube |
|
Radiotherapy of Head and Neck cancer |
Clinical Research |
Beatson CC, Gartnavel Hospital |
|
Biological Ageing in Cancer and Chronic Disease |
Epigenetics |
WWCRC, Garscube |
|
Mitochondria and Cell Death |
Beatson Associate |
CRUK BI, Garscube |
|
Translational Pharmacology |
Clinical and Experimental Therapeutics |
WWCRC, Garscube |
|
Gene Regulation in Normal Haematopoietic Development and Disease |
Epigenetics |
WWCRC, Garscube |
|
Clinical Research |
Clinical Research |
Beatson CC, Gartnavel Hospital |
|
Epigenomics and Genome Organisation |
Epigenetics |
WWCRC, Garscube |
|
Wnt Signalling in Myelopoiesis and CLL |
Leukaemia Research Centre |
PoGLRC, Gartnavel Hospital |
|
Tumour Microenvironemnt and Proteomics |
Beatson Institute |
CRUK BI, Garscube |
|
Stem Cell Aging and Cancer |
Leukaemia Research Centre |
CRUK BI, Garscube |
|
Ross Cagan | Biology of Therapeutics | Molecular Pathology | WWCRC, Garscube |
John Le Quesne | Molecular Pathology | CRUK BI, Garscube | |
Tom Bird | Beatson Institute | CRUK BI, Garscube | |
Karen Blyth | Beatson Institute | CRUK BI, Garscube | |
Martin Bushell | Beatson Institute | CRUK BI, Garscube | |
Payam Gammage | Beatson Institute | CRUK BI, Garscube | |
Gareth Inman | Beatson Institute | CRUK BI, Garscube | |
Crispin Miller | Beatson Institute | CRUK BI, Garscube | |
Jen Morton | Beatson Institute | CRUK BI, Garscube | |
Ed Roberts | Beatson Institute | CRUK BI, Garscube |